Masamitsu Yanada

53PUBLICATIONS
98CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyRespiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|May 04, 2026
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in Japan: changes in practice patterns and outcomes during the past 20 years.

|Apr 28, 2026
Impact of CD34+ cell dose on outcomes of related allogeneic PBSCT in adult AML patients.

|Mar 02, 2026
Impact of Total Body Irradiation Dose in Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia.

Shohei Mizuno, Akiyoshi Takami, Koji Kawamura

|Jan 15, 2026
GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort study.

Satoshi Yamasaki, Masamitsu Yanada, Shohei Mizuno

|Oct 04, 2025
Comparison of single-unit umbilical cord blood transplantation and haploidentical transplantation using posttransplant cyclophosphamide during first complete remission of acute myeloid leukemia.

Masamitsu Yanada, Satoshi Yamasaki, Shohei Mizuno

|Jun 16, 2025
Prognostic factors for allogeneic haematopoietic cell transplantation outcomes in primary refractory acute myeloid leukaemia (2013-2022): A retrospective study by the adult acute myeloid leukaemia working group of the Japanese Society for Transplantation and Cellular Therapy.

Takaaki Konuma, Yoshimitsu Shimomura, Shohei Mizuno

Pageof 9

Frequent Collaborators

27 joint publications

Yoshiko Atsuta

21 joint publications

Naoyuki Uchida

19 joint publications

Shuichi Ota

16 joint publications

Tadakazu Kondo